文献速递泌尿系结石膀胱癌与上尿路尿路上皮癌前列腺增生与排尿功能障碍

全国医疗系统中常见泌尿外科操作后抗生素使用及相关结局

Post-procedural Antibiotic Use and Associated Outcomes After Common Urologic Procedures Across a National Healthcare System.
PubMed 文献 · Urology · 2022-11-02

该回顾性队列研究纳入2017年1月1日至2021年6月30日退伍军人健康管理局105家医院74629例泌尿内镜操作患者,36.7%接受术后抗生素(中位3天,IQR 3-6)。术后抗生素与艰难梭菌感染风险增加相关(校正RR 1.67,95%CI 1.13-2.45),未减少非计划返院(校正RR 1.032,95%CI 0.999-1.066)。

要点

  • 术后抗生素使用率36.7%,医院间O:E比值0.46-1.93差异大。
  • 术后抗生素组艰难梭菌感染0.27% vs 未使用组0.10%(校正RR 1.67)。
  • 非计划返院20.2% vs 17.2%,校正RR 1.032(95%CI 0.999-1.066)。

核心结论

  • 术后抗生素在泌尿外科操作后频繁处方且医院间差异大,与艰难梭菌感染风险增加相关但未减少非计划返院,需减少与指南不一致的使用。

研究设计与样本

  • 回顾性队列研究,纳入2017年1月1日至2021年6月30日退伍军人健康管理局105家医院74629例泌尿内镜操作患者。

主要发现

  • 27422例(36.7%)接受术后抗生素,中位3天(IQR 3-6)。
  • 非计划返院:接受术后抗生素组20.2% vs 未接受组17.2%(校正RR 1.032,95%CI 0.999-1.066)。
  • 艰难梭菌感染:接受术后抗生素组0.27% vs 未接受组0.10%(校正RR 1.67,95%CI 1.13-2.45)。
  • 术后抗生素使用O:E比值从最低使用四分位医院0.46至最高使用四分位医院1.93。

临床怎么用

  • 指南通常不推荐术后抗生素用于手术预防。
  • 作者认为需要努力减少与指南不一致的术后抗生素使用。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To quantify the benefits and harms of post-procedural antibiotic use after common urologic procedures. MATERIALS AND METHODS: This retrospective cohort study included patients who underwent an endoscopic urologic procedure (transurethral resection of bladder tumor, transurethral resection of prostate, or ureteroscopy) within the Veterans Health Administration between January 1, 2017 and June 30, 2021. A post-procedural antibiotic was any qualifying antibiotic prescribed for administration on the day after the procedure. Guidelines generally do not recommend post-procedural antibiotics for surgical prophylaxis. Outcomes included unplanned return visits and Clostridioides difficile infection within 30 days. Log-binomial models with risk-adjustment were used to measure the association between post-procedural antibiotic use and outcomes. Hospital-level observed-to-expected (O:E) ratios were constructed to compare post-procedural antibiotic use. RESULTS: There were 74,629 qualifying procedures across 105 hospitals; 27,422 (36.7%) received post-procedural antibiotics (median 3 days, IQR 3-6). An unplanned return visit occurred in 20.2% of patients who received post-procedural antibiotics vs 17.2% who did not (adjusted RR 1.032, 95% CI 0.999-1.066). C. difficile infection was diagnosed in 0.27% vs 0.10% in those who received and did not receive post-procedural antibiotics (adjusted RR 1.67, 95% CI 1.13-2.45). The O:E ratio for post-procedural antibiotic use ranged from 0.46 among hospitals in the lowest-use quartile to 1.93 in the highest-use quartile. CONCLUSION: Post-procedural antibiotics were frequently prescribed after urologic procedures with large inter-facility variability even after adjusting for case-mix differences. Post-procedural antibiotic use was associated with increased risk for C. difficile infection but not fewer unplanned return visits. Efforts to reduce guideline-discordant use of post-procedural antibiotics are needed.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Granado BAR, Alexander B, Steinberg RL, et al. Post-procedural Antibiotic Use and Associated Outcomes After Common Urologic Procedures Across a National Healthcare System. Urology. 2022. PMID: 36334771. doi:10.1016/j.urology.2022.10.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。